Healthcare -
Biotechnology - NASDAQ - NL
$ 18.92
-6.13 %
$ 2.12 B
Market Cap
-7.42
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
NewAmsterdam Pharma Company N.V.
| Revenue | 45.6 M |
| Cost Of Revenue | 113 K |
| Gross Profit | 45.4 M |
| Operating Expenses | 222 M |
| Operating Income | -176 M |
| Other Expenses | 65.3 M |
| Net Income | -242 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 45.6 | 12.8 | 95.9 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.1 | 0 | 0 | 0 | 0 |
| Gross Profit | 45.5 | 12.8 | 95.9 | 0 | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 221.9 | 197.1 | 116.8 | 36.4 | 5.4 |
| Selling, General and Administrative Expenses | 70.4 | 29.8 | 18.2 | 5.3 | 1.4 |
| Research and Development Expenses | 151.4 | 159.4 | 81.0 | 25.5 | 4.0 |
| Operating Income | (176.3) | (165.7) | (3.3) | (30.7) | (5.4) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 6.8 | 0 | 0 | 0 |
| Total Other Income | (65.3) | 5.5 | (17.6) | (6.0) | (0.3) |
| Pre-Tax Income | (241.6) | (160.2) | (21.1) | (36.7) | (5.7) |
| NET INCOME | |||||
| Tax Provision | 1 K | 27 K | 0 | 0 | 0 |
| Net Income | (241.6) | (176.9) | (21.1) | (36.7) | (5.7) |
| EPS | 2.56 | 2.15 | 1.11 | 3.34 | 1.15 |